Caliciviruses consist of a family of viruses that infect humans and animals. Human caliciviruses called noroviruses cause gastrointestinal disease, with the disease burden being enormous in all age groups. Death can occur in young children and the elderly. Noroviruses cause almost all outbreaks (>95%) of nonbacterial foodborne and waterborne disease that result in 23 million cases of gastroenteritis annually in the US. Rehydration therapy is currently the only treatment for disease and hand washing may reduce transmission. Diagnosis is challenging because universal primers to detect the viral RNA genome are not available, and no rapid, broadly-reactive enzyme immunoassay is approved in the US. Effective antivirals could be useful to stop spread of virus in semi-closed environments and treat chronically infected individuals. This Program Project application integrates the efforts of a molecular virologist, a physician scientist, a biophysical chemist/microbiologist with expertise in proteomics, a structural biologist, and a newly recruited medicinal chemist interested in small molecule inhibitors. This integrated team will build on previous basic science experience and discoveries to allow rapid progress on current applied needs related to public health and understanding of viral pathogenesis. Project 1 will develop new, broadly-reactive diagnostic assays to detect noroviruses and identify lead antiviral compounds to inhibit key targets required for viral replication. Project 2 will develop methods to propagate noroviruses in cultured cells and dissect the molecular basis of host restriction of viral replication. Project 3 will pursue high resolution structural information on the viral capsid and viral proteins critical for genome replication to facilitate structure -based development and testing of antivirals. Each project is dependent on the experimental and intellectual contributions of 3 Core facilities: the Administration Core, Microscopy Core, and the Protein and Small Molecule Chemistry Core. Proposed, continued research by this Program Project team is expected to make new fundamental discoveries that will be important in the diagnosis, treatment, prevention and understanding of the biology of these epidemiologically significant human pathogens.
Human caliciviruses cause gastrointestinal disease and the disease burden is enormous in all age groups. This Program Project grant proposes continued studies by a highly productive, integrated team of basic and clinical investigators to use multidisciplinary approaches to develop new tests and drugs for diagnosis, treatment and prevention of disease caused by these important human pathogens.
|Qu, Lin; Murakami, Kosuke; Broughman, James R et al. (2016) Replication of Human Norovirus RNA in Mammalian Cells Reveals Lack of Interferon Response. J Virol 90:8906-23|
|Ettayebi, Khalil; Crawford, Sue E; Murakami, Kosuke et al. (2016) Replication of human noroviruses in stem cell-derived human enteroids. Science 353:1387-1393|
|Prasad, Bv Venkataram; Shanker, Sreejesh; Muhaxhiri, Zana et al. (2016) Antiviral targets of human noroviruses. Curr Opin Virol 18:117-25|
|Shanker, Sreejesh; CzakÃ³, Rita; Sapparapu, Gopal et al. (2016) Structural basis for norovirus neutralization by an HBGA blocking human IgA antibody. Proc Natl Acad Sci U S A 113:E5830-E5837|
|Ramani, Sasirekha; Neill, Frederick H; Opekun, Antone R et al. (2015) Mucosal and Cellular Immune Responses to Norwalk Virus. J Infect Dis 212:397-405|
|Kou, Baijun; Huang, Wanzhi; Neill, Frederick H et al. (2015) Norovirus Antigen Detection with a Combination of Monoclonal and Single-Chain Antibodies. J Clin Microbiol 53:3916-8|
|Ye, X; Van, J N; Munoz, F M et al. (2015) Noroviruses as a Cause of Diarrhea in Immunocompromised Pediatric Hematopoietic Stem Cell and Solid Organ Transplant Recipients. Am J Transplant 15:1874-81|
|Henning, Susan J; Estes, Mary K (2015) Women in Science: Hints for Success. Gastroenterology 149:10-3|
|Crawford, Sue E; Ajami, Nadim; Parker, Tracy Dewese et al. (2015) Mapping broadly reactive norovirus genogroup I and II monoclonal antibodies. Clin Vaccine Immunol 22:168-77|
|Hesse, Shayla; Neill, Frederick H; Estes, Mary K et al. (2015) Serological Responses to a Norovirus Nonstructural Fusion Protein after Vaccination and Infection. Clin Vaccine Immunol 23:181-3|
Showing the most recent 10 out of 75 publications